Will Johnson & Johnson’s Plan to Retool Its Medical Device Business Succeed?

johnson-johnson-logoBig changes are afoot in the medical device industry, and Johnson & Johnson (NYSE:JNJ) is in the driver’s seat. When the largest among medical device companies makes a move, the industry tends to stop and pay attention.

J&J has witnessed its operational performance completely flip-flop over the past decade. In the 1990s and 2000s, medical device growth was strong whereas pharmaceutical growth was hit-and-miss. Nowadays, we’re observing the opposite, with J&J bringing seven blockbuster drugs and 14 novel medicines in total to pharmacy shelves since 2009, and medical device growth traipsing along at a meager 1% as of the most recent quarter.


About Peter Coffaro 1102 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.